Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The phrase "tyrosine metabolism enzymes" refers collectively to a group of enzymes that mediate pathways for the biosynthesis and catabolism of tyrosine, an aromatic amino acid essential for protein synthesis, neurotransmitter production (dopamine, norepinephrine, epinephrine), hormone synthesis (thyroid hormones), and the formation of other bioactive molecules. Key enzymes include phenylalanine hydroxylase (converts phenylalanine to tyrosine), tyrosine aminotransferase (initiates tyrosine degradation), tyrosine hydroxylase (initiates catecholamine biosynthesis), DOPA decarboxylase, and others. Dysfunction or deficiency of individual enzymes is associated with specific metabolic diseases (e.g., different forms of tyrosinemia, alkaptonuria, phenylketonuria), cancer risk, and neurological disorders[1][2][3][6][8]. As a plural group, "tyrosine metabolism enzymes" is not a valid or actionable therapeutic target for the purposes of drug development or biomarker selection[1][2][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tyrosine metabolism enzymes.